NEW YORK (Reuters Health) – In patients with moderate-severe COVID-19, recombinant super-compound interferon (rSIFN-co) plus baseline antivirals was associated with a shorter time to clinical improvement than the same regimen using traditional interferon-alpha in an exploratory trial in China. “Since no antiviral agents were confirmed to be effective for COVID-19 during our study period, there […]
The common cold virus could offer some level of protection against COVID-19 infection, according to a new study. The research—published today in Journal of Infectious Diseases and led by scientists at the MRC-University of Glasgow Centre for Virus Research (CVR) – found that human rhinovirus (the virus that causes the common cold) triggers an innate […]
LONDON (Reuters) – Confidence in the safety of AstraZeneca’s COVID-19 vaccine has taken a big hit in Spain, Germany, France and Italy as reports of rare blood clots have been linked to it and many countries briefly stopped using it, poll data showed on Monday. The polling firm YouGov said it had already found in […]
COPENHAGEN (Reuters) – Denmark said on Saturday that one person had died and another fell seriously ill with blood clots and cerebral haemorrhage after receiving the AstraZeneca COVID-19 vaccination. The two, both hospital staff members, had both received the AstraZeneca vaccine less than 14 days before getting ill, the authority that runs public hospitals in […]
COPENHAGEN/OSLO/STOCKHOLM (Reuters) – Denmark, Sweden and Norway said on Friday they needed more time to decide whether to use AstraZeneca’s COVID-19 vaccine even though the EU drug watchdog said the benefits outweighed the risks, prompting several countries to resume its use. “We need time to get to the bottom of this,” Soren Brostrom, head of […]
Some patients with moderate to severe COVID-19 disease seem to experience inflammation of the thyroid gland that is different from thyroid inflammation caused by other viruses, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting. One-third of the study participants still had signs of thyroid inflammation after three months, even […]
People in prisons are at an increased risk of COVID-19—with a death rate over three times higher than that of the general population—and should be made a vaccine priority, according to UCL-led team of researchers. In an article published today in The Lancet Respiratory Medicine, the research team reveals that there were 121 deaths related […]
Fewer than 1% of COVID-19 survivors are reinfected with the virus – but those aged 65 or older are nearly 50% more likely to get the disease twice compared to younger people, new study finds Researchers looked at people in Denmark who were tested for coronavirus during the first wave and the second wave Just 0.65% […]
(Reuters Health) – The AstraZeneca COVID-19 vaccine developed with the University of Oxford has an efficacy of only 10.4% against the South African variant of the virus, according to data published online Wednesday by The New England Journal of Medicine. In the test on 2,026 HIV-negative volunteers, mild-to-moderate disease caused by any type of SARS-CoV-2 […]
(Reuters) – Canadian drug developer Medicago said on Tuesday it had started a late-stage study of its experimental COVID-19 vaccine combined with an adjuvant from GlaxoSmithKline. The study plans to eventually enroll 30,000 participants and initially focus on healthy adults, followed by adults over the age of 65 and those with co-morbidities. Medicago, which has […]
